Phase III sbir research and development contract for project titled "canine freeze dried plasma system"

Ended Definitive Contract Awarded Last action

Contract number
W81XWH22C0127
Awardee
Awarding agency
Obligated
$8,761,227

Award facts

Opportunity
  • W81XWH22R0044 Solicitation number
Contract value 100% obligated
$8,761,227.30 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 1 offer Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Tacoma, WA 98403, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00007 · Phase III sbir canine freeze-dried plasma $485,739
Supplemental Agreement for work within scope P00006 · Canine plasma $541,863
Exercise an Option P00005 · Canine freeze dried plasma $1,245,334
Funding Only Action P00004 · Sbir phase 3 medical research and development contract for canine freeze dried plasma $1,797,417
Other Administrative Action P00003 · Canine freeze dried plasma $0
Other Administrative Action P00002 · Canine freeze dried plasma sbir phase III medical r & d contract $2,690,874
Other Administrative Action P00001 · Per section 711 of the 2019 ndaa, usamraa transferred to DHA 10/1/2022. Canine freeze dried plasma $0
Original award $2,000,000

About this award

The Defense Health Agency awarded Mantel Technologies, Inc. a Phase III Small Business Innovation Research (SBIR) contract on September 16, 2022, for the development and commercialization of a canine freeze-dried plasma system. This definitive contract, valued at $8.76 million with a completion date of September 30, 2026, represents the final commercialization phase of a technology designed to provide medical capabilities for military working dogs. The contract is structured as a cost-plus-fixed-fee arrangement and carries a total small business set-aside designation, reflecting the Department of Defense's commitment to leveraging innovative solutions from small businesses. Mantel Technologies, a small business manufacturer based in Fort Collins, Colorado, will perform the work at its facility in Tacoma, Washington.

This award builds upon Mantel Technologies' demonstrated expertise in canine-related defense technologies and their track record of securing substantial SBIR funding from multiple defense agencies, including the Office of Naval Research, Army, Air Force Research Laboratory, and U.S. Special Operations Command. The company's experience in developing advanced medical and physiological monitoring systems for military applications, combined with their established relationships within the defense innovation ecosystem, positions them well to bring this freeze-dried plasma system from prototype to operational readiness for military veterinary medicine applications.

Quick answers

Who was awarded contract W81XWH22C0127?

W81XWH22C0127 was awarded to Mantel Technologies, Inc. by Defense Health Agency (Department of Defense) on September 16, 2022.

How much is contract W81XWH22C0127 worth?

The government has obligated $8,761,227 on W81XWH22C0127.

Was contract W81XWH22C0127 competed?

The extent of competition for W81XWH22C0127 was full and open competition after exclusion of sources. The government received 1 offer. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award